Philadelphia-based Virion Therapeutics also presented positive results from its early-stage study of VRON-0200, a new hepatitis B drug. The trial, which involved 13 patients, showed that the drug ...

Let's dive into the world of hepatitis A, B, C, D, and E – five viruses that can affect your liver, each with its own unique ...